| 1621/1816 | US=55 / Biol/Mol Meier C, Balzarini J, Meerbach A. The cycloSal-nucleotide delivery system: development of chemical trojan horses as antiviral agents. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 353-401. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. SISTEMA DE ENTREGA; CICLOSAL DE NUCLEOTIDEO; AGENTES ANTIVIRAIS |
| 1622/1816 | US=55 / Biol/Mol Gojkovic Z, Karlsson A. Purine and pyrimidine-based analogs and suicide gene therapy. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 403-39. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. PURINA; ANALOGOS DE PIRIMIDINA-BASE; TERAPIA DE GENE SUICIDA; ACICLOVIR; CITOSINA DESAMINASE; DESOXINUCLEOSIDO QUINASE; SISTEMA DE ENTREGA DE DROGA; FLUOROCITOSINE; GANCICLOVIR; TERAPIA GENICA; TIMIDINA QUINASE DO HERPES; GENES SUICIDAS; TIMIDINA QUINASE |
| 1623/1816 | US=55 / Biol/Mol Direcks WGE, Lammertsma AA, Molthoff CFM. 3-deoxy-3-fluorothymidine as a tracer of proliferation in positron emission tomographyPurine and pyrimidine-based analogs and suicide gene therapy. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 441-62. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. 3-DESOXI-3-FLUOROTIMIDINA; MARCADOR DE PROLIFERACAO; TOMOGRAFIA POR EMISSAO DE POSITRONS |
| 1624/1816 | US=59 / Enfermagem Goldstein ML, Byrnes-Casey M, Collins JJ. Pediatric palliative care: pediatric pain: knowing the child before you. In: Ferrell BR, Coyle N. Textbook of palliative nursing. Oxford: University Press, 2006. p. 991-1008. ISBN 978-0-19-51549-3. PEDIATRICA. CUIDADOS PALIATIVOS; DOR PEDIATRICA; DOR NEUROPATICA; QUEIMADURAS; CANCER; INFECCAO POR VIRUS DA IMUNODEFICIENCIA HUMANA; DOENCA DAS CELULAS SICKEL; ARTRITE CRONICA JUVENIL; FIBROSE CISTICA |
| 1625/1816 | US=61 / Biol/Mol Spalding SM, Angel SO, Amendoeira MRR. Toxoplasmose. In: Rossetti ML, Silva CMD, Rodrigues JJS. Doenças infecciosas diagnóstico molecular. Rio de Janeiro: Guanabara-Koogan, 2006. p. 102-111. ISBN 85-2771083-8. TOXOPLASMOSE HUMANA; TOXOPLASMA GONDII; TRANSMISSAO DA TOXOPLASMOSE; DIAGNOSTICO MOLECULAR |
| 1626/1816 | US=61 / Câncer Dewhirst MW, Cao Y, Moeller B, Li CY. Physiological resistance: the cycle between angiogenesis perfusion, and hypoxia in tumors. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 1-19. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. |
| 1627/1816 | US=61 / Câncer Song CW, Griffin R, Park HJ. Physiological resistance: influence of tumor pH on therapeutic response. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 21-42. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. INTRATUMOR PH; PH EXTRACELULAR; PH INTRACELULAR; INTRATUMORAL MECANISMO DE CONTROLO DE PH; QUIMIOTERAPIA; RADIOTERAPIA; HIPERTERMIA |
| 1628/1816 | US=61 / Câncer Lunt SJ, Hill RP. Physiological resistance: tumor oxygenation and treatment response. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 43-66. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. HIPOXIA TUMOR; HIF-1; MARCADORES DE HIPOXIA; DROGAS BIORREDUTIVA; DIRIGIDO GENE-ENZIMA PRO-DROGA TERAPEUTICA |
| 1629/1816 | US=61 / Câncer Rak JW, Coomber B, Yu JL. Physiological resistance: oncogenes and tumor suppressor genes in therapeutic resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 67-103. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. ONCOGENES; GENES SUPRESSORES DE TUMORES; RESISTENCIA AS DROGAS; MICROAMBIENTE; INTERACOES TUMOR-HOSPEDEIRO |
| 1630/1816 | US=61 / Câncer Mankoff DA, Krohn KA. Physiological resistance: PET imaging of response and resistance to cancer therapy. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 105-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. CANCER DE IMAGENS; PET; RESPOSTA; RESISTENCIA; IMAGIOLOGIA MOLECULAR |
| 1631/1816 | US=61 / Câncer Mantle I, Dontu G, Liu S, Wicha MS. Biological resistance: cancer stem cells. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 125-36. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. QUIMIOTERAPIA CITOTOXICA; DESREGULACAO; HETEROGENEIDADE TUMOR; TUMOR DE CELULAS ESTAMINAIS; MODELO DE TUMOR DE CELULAS-TRONCO |
| 1632/1816 | US=61 / Câncer Waud WR. Biological resistance: therapeutic resistance in leukemia. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 137-50. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. LEUCEMIA P388; LINHAS TUMORAIS RESISTENTES A DROGAS; RESISTENCIA AS DROGAS; RESISTENCIA TERAPEUTICA |
| 1633/1816 | US=61 / Câncer Arjona AA, Alvarez E. Biological resistance: tumor site implantation and animal model selection in oncology. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 151-9. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. LOCAL DO TUMOR; IMPLANTACAO SUBCUTANEA; TUMORES INTRADERMICOS; ANGIOGENESE; HIPOXIA |
| 1634/1816 | US=61 / Câncer Teicher BA. Biological resistance: in vivo resistance. In: ___. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 161-79. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. RESISTENCIA A CISPLATINA; RESISTENCIA CICLOFOSFAMIDA; EMT-6 CARCINOMA MAMARIO; RESISTENCIA IN VIVO; FATOR DE CRESCIMENTO TRANSFORMANTE-B |
| 1635/1816 | US=61 / Câncer Melnikova VO, Bar-Eli M. Biological resistance: characteristics of the metastatic phenotype. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 181-200. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. MELANOMA; METASTASE; ANGIOGENESE; REGULACAO TRANSCRICIONAL; AP-2; CREB |
| 1636/1816 | US=61 / Câncer Morin PJ. Biological resistance: the microenvironment and drug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 201-10. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. MICROAMBIENTE; MATRIZ EXTRACELULAR; CITOCINAS; FACTORES DE CRESCIMENTO; RESISTENCIA AS DROGAS; APOPTOSE; ANOIKIS |
| 1637/1816 | US=61 / Câncer Findlay VJ, Townsed DM, Tew KD. Biochemical resistance: glutathione S-transferases in drug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 213-21. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. GLUTATIONA; GLUTATIONA-S-TRANSFERASE; RESISTENCIA AS DROGAS; CANCER; MAPK; CAMINHO |
| 1638/1816 | US=61 / Câncer Notta F, Koropatnick DJ. Biochemical resistance: metallothioneins in drug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 223-39. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. METALOTIONEINAS; GLUTATIONA; CISPLATINA; VARREDORES DE RADICAIS LIVRES; SULFIDRILOS PROTEINA |
| 1639/1816 | US=61 / Câncer Monti E. Biochemical resistance: molecular determinants of intrinsic multidrug resistance in cancer cells and tumors. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 241-60. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. |
| 1640/1816 | US=61 / Câncer Bates SE, Deeken J, Fan C, Robey RW. Biochemical resistance: new and revised concepts in multidrug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 261-82. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. MULTIRRESISTENCIA; SNPS; GP170; SETAMIBI; MULTIRRESISTENCIA; DERIVAM DE CELULAS |